TipRanks
Go Ultimate55% OFF

AFLAC (1AFL) AI Stock Analysis

0 Followers
IT:1AFL

AFLAC

(Milan:1AFL)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
U.S. premium and platform growthU.S. growth across group life, disability, consumer markets, dental, vision, and voluntary benefits demonstrates broadening distribution and product adoption. Rising premiums and persistency can support recurring revenue, while cross-selling across employer channels may strengthen customer retention and long-term economics.
Negative Factors
Revenue and earnings trajectory under pressureA weaker top line and earnings decline indicate that recent profitability has not translated into consistent growth. If revenue remains flat or contracts, operating leverage and reinvestment capacity may weaken, making it harder to sustain earnings expansion despite currently strong reported margins.

AFLAC (1AFL) vs. iShares MSCI Italy ETF (EWI)

-10%-5%0%5%10%15%20%25%IT:1AFL+16.51%EWI+9.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 63.29B
Dividend Yield
1.83%
Average Volume (3M)
115
Price to Earnings (P/E)
18.5
Beta (1Y)
0.86
Revenue Growth
-11.06%
EPS Growth
-14.41%
Country
Italy
Employees
12,716
Sector
Financial
Sector Strength
68
Industry
Insurance - Life

AFLAC Business Overview & Revenue Model

Company Description

Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Ja...

AFLAC Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|% Change Since:0.99%|Next Earnings Date:Feb 03, 2026
Earnings Call SentimentPositive

The call was broadly positive. Management reported solid adjusted earnings, strong capital and liquidity, favorable US growth, raised 2026 Japan and US profitability expectations, substantial shareholder returns, and additional reinsurance and investment opportunities. These strengths outweighed the quarterly Japan sales decline, lower adjusted book value, cybersecurity-related disruption and expenses, investment valuation charges, mixed investment income, and continued pressure in selected businesses.

Positive Updates

Strong Adjusted Earnings and Returns
Third quarter adjusted earnings per diluted share were reported as $2.43 by Daniel Amos and $2.46 excluding foreign currency by Max Broden; Max stated that adjusted earnings per diluted share decreased 1.2% year over year to $2.46. Adjusted ROE was 17.8%, or 23.7% excluding foreign currency remeasurement, described as a significant spread to the company's cost of capital.

Negative Updates

Japan Quarterly Sales Decline
Aflac Japan third-quarter sales declined 4% to ¥18.8 billion, reflecting the challenging year-ago comparison following the Miraito Cancer Insurance launch.

Company Guidance

Aflac continues to expect Aflac Japan sales to exceed 2025, with 2026 Japan benefit ratio slightly below the 60 to 63% range, expense ratio on the lower end of the 2023% range, and pretax profit margin of 35 to 38%; in the US, 2026 benefit ratio is expected to be below the 48 to 52% range, expense ratio in the middle of the 36 to 39% range, and pretax profit margin above the 17 to 20% range. Aflac Japan has ceded about 15% of total FSA reserves versus an internal risk limit of 30%, leaving very meaningful runway for further reinsurance transactions. The company expects the fourth quarter to be better than last year, including an extra week of productivity, and expects Tsumitasu to continue to play an important role in 2027.

AFLAC Risk Analysis

AFLAC disclosed 28 risk factors in its most recent earnings report. AFLAC reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

AFLAC Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

IT:1AFL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
METMET76Outperform$65.38B12.9219.46%2.35%14.99%44.29%
GLGL73Outperform$12.43B10.4619.09%0.79%5.62%8.90%
PRUPRU69Neutral$43.69B10.9812.05%4.53%6.46%50.56%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
LNCLNC64Neutral$7.96B3.9831.63%4.60%7.38%45.23%
UNMUNM62Neutral$11.84B52.452.23%2.61%-4.15%-72.51%

* Financial Sector Average

Performance Comparison

-20%0%20%40%IT:1AFLLNCMETPRUGLUNMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IT:1AFL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IT:1AFLAFLAC Incorporated112.5516.9017.67%
LNCLincoln National40.050.822.09%
METMetlife98.2723.1330.79%
PRUPrudential Financial119.2417.6217.34%
GLGlobe Life Inc.157.1825.4919.35%
UNMUnum Group76.751.211.60%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.